437 related articles for article (PubMed ID: 19102401)
1. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
[TBL] [Abstract][Full Text] [Related]
3. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
[TBL] [Abstract][Full Text] [Related]
4. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
[TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasms of the pancreas: performance of pancreatic fluid analysis for positive diagnosis and the prediction of malignancy.
Maire F; Voitot H; Aubert A; Palazzo L; O'Toole D; Couvelard A; Levy P; Vidaud M; Sauvanet A; Ruszniewski P; Hammel P
Am J Gastroenterol; 2008 Nov; 103(11):2871-7. PubMed ID: 18775021
[TBL] [Abstract][Full Text] [Related]
6. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms.
Yoon WJ; Ryu JK; Lee JK; Woo SM; Lee SH; Park JK; Kim YT; Yoon YB
Ann Surg Oncol; 2008 Nov; 15(11):3193-8. PubMed ID: 18784959
[TBL] [Abstract][Full Text] [Related]
7. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
[TBL] [Abstract][Full Text] [Related]
8. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas.
Corcos O; Couvelard A; Dargère D; Sauvanet A; Hammel P; Paradis V; Lévy P; Ruszniewski P; Bedossa P
Pancreas; 2012 Mar; 41(2):169-74. PubMed ID: 22076567
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic juice cytology in IPMN of the pancreas.
Yamaguchi K; Nakamura M; Shirahane K; Kawamoto M; Konomi H; Ohta M; Tanaka M
Pancreatology; 2005; 5(4-5):416-21; discussion 421. PubMed ID: 15985766
[TBL] [Abstract][Full Text] [Related]
10. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
[TBL] [Abstract][Full Text] [Related]
11. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
[TBL] [Abstract][Full Text] [Related]
12. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas.
Ingkakul T; Sadakari Y; Ienaga J; Satoh N; Takahata S; Tanaka M
Ann Surg; 2010 Jan; 251(1):70-5. PubMed ID: 20009749
[TBL] [Abstract][Full Text] [Related]
15. MUC1 is a useful molecular marker for malignant intraductal papillary mucinous neoplasms in pancreatic juice obtained from endoscopic retrograde pancreatography.
Shimamoto T; Tani M; Kawai M; Hirono S; Ina S; Miyazawa M; Shimizu A; Uchiyama K; Yokoyama S; Tsutsumi M; Yamaue H
Pancreas; 2010 Aug; 39(6):879-83. PubMed ID: 20357691
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
[TBL] [Abstract][Full Text] [Related]
17. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
[TBL] [Abstract][Full Text] [Related]
19. Multifocal pancreatic ductal adenocarcinomas concomitant with intraductal papillary mucinous neoplasms of the pancreas detected by intraoperative pancreatic juice cytology. A case report.
Mori Y; Ohtsuka T; Tsutsumi K; Yasui T; Sadakari Y; Ueda J; Takahata S; Nakamura M; Tanaka M
JOP; 2010 Jul; 11(4):389-92. PubMed ID: 20601817
[TBL] [Abstract][Full Text] [Related]
20. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
